#Thinksabio latest news
BioCardia Announces Pricing of Up To $12 Million Public Offering$6 million upfront with up to an additional $6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
BioCardia Announces Pricing of Up To $12 Million Public Offering$6 million upfront with up to an additional $6 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants